Danaher Corp. said it would buy medical diagnostics company Cepheid in a deal valued at $4 billion that will strengthen its presence in molecular diagnostics.
Tonix Pharmaceuticals Holding Corp. said it would stop developing its drug for fibromyalgia after the treatment failed in a late-stage trial.
An experimental three-in-one inhaled drug from GlaxoSmithKline significantly cut flare-ups in patients with chronic lung disease in a clinical trial, researchers said.
Now that the Pfizer acquisition of Medivation is basically a done deal, more details are coming out about how the deal went down and Medivation chief executive officer David Hung’s share of the winnings.
Most patients diagnosed with type 2 diabetes in Japan are not classified as overweight or obese according to new research conducted by Kantar Health, a leading global healthcare consulting and research firm.
Babies given antibiotics in the first two years of life are more likely to develop allergies as adults, according to an extensive analysis of past clinical studies involving nearly 400,000 people.
The world’s 300 million asthma sufferers could help reduce their risk of severe asthma attacks by taking vitamin D supplements as well as their standard asthma medicines, according to the findings of a review of international trial evidence.
The U.S. Food and Drug Administration halted the sale of some antibacterial over-the-counter hand and body wash products, saying they were not more effective than plain soap and water in preventing illnesses and reducing the spread of infections.
A group of Hungarian researchers at the Eotvos Lorand University in Budapest have scanned the brains of 13 dogs, finding that dogs process words and intonation to work out messages similarly to humans.
The arrival in Florida of Zika, a virus that can cause a crippling birth defect known as microcephaly, has drawn into focus the limitations of the U.S. mosquito control arsenal.
Merck & Co. Inc. said it would stop developing its experimental osteoporosis drug after an independent analysis confirmed the treatment raises the risk of stroke.
San Diego-based Arena Pharmaceuticals announced that it had created an independent, privately held drug discovery incubator called Beacon Discovery.
FDA Approves BLINCYTO For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Amgen announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Japanese drugmaker Takeda Pharmaceutical Co. said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency.
Novo Nordisk’s chief executive Lars Rebien Sorensen is to step down at a time when the world’s largest insulin maker has said it faces increased U.S. competition.
Novartis AG’s dissolving of its Gene and Cell Therapy Unit sent ripples across the CAR-T company market, causing shares of Juno Therapeutics and Kite Pharma to drop in trading.
Parexel Loses $160 Million in Value in One Day After Disclosing Possible ‘Misappropriation of Corporate Funds’
Shares of contract research organization Parexel dropped nearly 5 percent in one day, causing the company to lose about $160 million in value after the company announced it was delaying filing its 10-K following the discovery of the misappropriation of funds by an employee.
Swiss drugmaker Roche Holding AG, seeking to expand uses for its drug Tecentriq beyond bladder cancer, said a study had shown the new immunotherapy helped people with lung cancer live longer than with chemotherapy.